In nude mice xenograft model, AMTB treatment augmented tumor cells’ sensitivity to cisplatin, by smodering Smad2 and Smad3 phosphorylation and, therefore, repressing the activation of TGFβ signaling, which was implicated in tumorigenesis and tumor progression (207, 351). Here, SMAD2 is linked to neoplasm.